Amy Gutshall, APRN
Psychiatric/Mental Health · Morgantown, WVNPI 1750934816
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 28.7% of the total. 2025 is the largest year on record at $1,166, more than ten times the $43 reported in 2021.
Across 189 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$892
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$304
- Alkermes, Inc.$264
- Teva Pharmaceuticals USA, Inc.$173
- Otsuka America Pharmaceutical, Inc.$170
- Vanda Pharmaceuticals Inc.$168
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,109100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 73 | $892 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $304 |
| Alkermes, Inc. | 14 | $264 |
| Teva Pharmaceuticals USA, Inc. | 10 | $173 |
| Otsuka America Pharmaceutical, Inc. | 9 | $170 |
| Vanda Pharmaceuticals Inc. | 7 | $168 |
| Johnson & Johnson | 6 | $135 |
| Indivior Inc. | 7 | $129 |
| Axsome Therapeutics, Inc. | 6 | $121 |
| Corium, LLC | 6 | $117 |
| Neurocrine Biosciences, Inc. | 7 | $112 |
| Novo Nordisk | 5 | $81 |
| Lundbeck LLC | 2 | $64 |
| Ironshore Pharmaceuticals Inc. | 3 | $55 |
| Novartis | 3 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Organon | 2 | $48 |
| Lilly USA, LLC | 2 | $45 |
| Almatica Pharma LLC | 2 | $35 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $15 |
| Tris Pharma Inc | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
How this compares
$3,109 in reported general payments places this provider in the 85th percentile of 142 psychiatric/mental health providers in West Virginia.
See all psychiatric/mental health providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 12 | $10,398 |
| Aripiprazole | 17 | $4,117 |
| Bupropion XlBupropion Hcl | 63 | $1,455 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 23 | $892 |
| Duloxetine Hcl | 53 | $656 |
| Buspirone Hcl | 34 | $565 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $547 |
| Prazosin Hcl | 23 | $447 |
| Clonazepam | 110 | $446 |
| Topiramate | 13 | $406 |
| Lamotrigine | 38 | $385 |
| Doxepin Hcl | 18 | $368 |
| Quetiapine Fumarate | 28 | $322 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $309 |
| Hydroxyzine Pamoate | 17 | $283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $35 | $26633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 142 psychiatric/mental health providers in West Virginia.
Other psychiatric/mental health in Morgantown
- Craig HaagenMorgantown$2K
- Jeremy SchreiberWheeling$1.7M
- Kimberly RittenhouseParkersburg$7K
- Michael SkaggsRipley$7K
- Larry RobertsonHuntington$6K
- Gwendolyn HuffmanSummersville$6K
- Summer DevolParkersburg$5K
- Osric Malone-PrioleauSaint Marys$5K
- Mercedes WeikleFort Gay$5K
- Shannon PembertonBarboursville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.